The cna Gene: Structure, Function, and Clinical Role

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-01

Key Takeaways

• The cna gene encodes the Staphylococcus aureus collagen adhesin (CNA), a surface protein crucial for bacterial adherence to collagen-rich host tissues, thereby initiating infections like prosthetic joint infections, osteomyelitis, and endocarditis.
• CNA's structure features an N-terminal A-domain for collagen binding and variable B-repeats that modulate avidity, with sortase A mediating its anchoring to the bacterial cell wall via an LPXTG motif.
• Transcriptional regulation of cna is primarily repressed by the staphylococcal accessory regulator SarA in an agr-independent manner, with expression peaking during exponential growth phase, reflecting a coordinated virulence strategy.
• The prevalence of the cna gene is significantly higher in strains causing prosthetic joint infections (60-80%) and is often co-associated with methicillin resistance (MRSA), suggesting its role as a key virulence determinant in specific S. aureus pathotypes.
• CNA is a potential therapeutic target for anti-virulence strategies, including monoclonal antibodies or small-molecule inhibitors designed to block collagen binding, and its presence can be detected via PCR for diagnostic purposes.

Executive Summary & Key Metadata

The cna gene encodes the collagen adhesin protein (CNA), a cell wall-anchored surface protein belonging to the microbial surface components recognizing adhesive matrix molecules (MSCRAMM) family in Staphylococcus aureus [1]. CNA mediates bacterial adherence to collagen-rich host tissues, a critical early step in the pathogenesis of prosthetic joint infections, osteomyelitis, septic arthritis, and endocarditis [1, 2, 3]. Beyond its role in staphylococcal virulence, the term "CNA" is widely used in oncology as an acronym for copy number alteration, a class of somatic genomic aberrations that drive tumorigenesis across multiple cancer types [4, 5, 6, 7]. This dual usage, as a specific microbial gene and as a broad genomic phenomenon, necessitates careful contextual interpretation. This reference manual focuses primarily on the microbial collagen adhesin gene cna (UniProt P08083) while integrating the oncological CNA literature where relevant to clinical diagnostics and therapeutic targeting.

1. Genomic Locus, Chromosomal Organization & Isoforms

1.1 Chromosomal Location and Genetic Element Structure

The cna gene in Staphylococcus aureus is not located at a fixed chromosomal position across all strains; rather, it resides within a discrete genetic element that can vary in genomic context [8]. Gillaspy et al. (1997) demonstrated that cna is contained within a defined chromosomal region that may be horizontally transferred or subject to genomic rearrangements [8]. The gene spans approximately 2.3 kilobases (kb) and encodes a precursor protein of roughly 1,183 amino acids, including a signal peptide, an N-terminal A-domain (collagen-binding), a series of B-repeats, a cell wall-spanning region, and a C-terminal LPXTG motif for sortase-mediated anchoring [1].

The genetic element harboring cna often includes flanking insertion sequences and remnants of mobile genetic elements, suggesting acquisition via horizontal gene transfer [8]. This genomic plasticity contributes to the variable prevalence of cna among clinical isolates, ranging from ~30% to 80% depending on the source (e.g., prosthetic infections, mastitis, food isolates) [2, 3, 9, 12, 18].

1.2 Promoter Architecture and Transcriptional Regulation

The promoter region of cna contains binding sites for multiple transcriptional regulators. Blevins et al. (1999) established that the staphylococcal accessory regulator SarA represses cna transcription in an agr-independent manner [14]. This repression is mediated through direct binding of SarA to the cna promoter region, likely at a site overlapping the −35 or −10 promoter elements, thereby sterically hindering RNA polymerase holoenzyme binding [14, 15].

Gillaspy et al. (1997) further characterized the transcriptional regulation of cna, identifying growth-phase-dependent expression with maximal transcription during the exponential phase and downregulation upon entry into stationary phase [15]. This pattern is consistent with the activity of global regulators such as SarA and Agr, which modulate virulence gene expression in response to cell density and environmental cues [14, 15].

1.3 Transcription Factor Binding Sites and Enhancer Elements

DNase I footprinting and electrophoretic mobility shift assays (EMSAs) have localized SarA binding to a region spanning nucleotides −80 to −40 relative to the transcriptional start site [14]. This region contains a palindromic sequence motif (5′-ATTAATTA-3′) that is conserved among SarA-regulated promoters. Additionally, the cna promoter contains a putative σ^A-dependent −10 box (TATAAT) and a −35 box (TTGACA) with moderate sequence conservation, indicating that basal transcription is mediated by the housekeeping sigma factor [15].

No classical enhancer elements have been identified for cna; however, the presence of upstream AT-rich regions may facilitate DNA bending and promoter accessibility. The discrete genetic element context may also introduce position-dependent effects on promoter activity due to chromatin-like nucleoid structuring [8].

1.4 Alternative Splicing and Isoforms

Unlike eukaryotic genes, cna does not undergo alternative splicing. However, allelic variation and phase-variable recombination within the B-repeat region generate protein isoforms with differing numbers of B-repeats (typically 1 to 5 repeats of a 187-amino-acid motif) [1]. These isoforms exhibit altered collagen-binding avidity and may influence tissue tropism. The A-domain, which contains the actual collagen-binding site, is highly conserved across strains, whereas the B-repeats show length polymorphism [1].

2. 3D Protein Domain Architecture & Structural Biology

2.1 Domain Organization

The CNA precursor protein is organized into distinct functional domains from the N-terminus to the C-terminus:

1. Signal Peptide (residues 1–40): Directs secretion via the Sec pathway.
2. A-Domain (residues 41–529): The ligand-binding domain; folds into a β-barrel with a trench-like collagen-binding pocket.
3. B-Repeats (residues 530–903): 1–5 tandem repeats of ~187 residues; extend the protein from the cell surface and may modulate binding avidity.
4. Cell Wall Spanning Region (residues 904–1,130): Rich in proline and glycine; traverses the peptidoglycan layer.
5. LPXTG Motif (residues 1,131–1,135): Recognized by sortase A, which covalently anchors CNA to the cell wall peptidoglycan.
6. Hydrophobic Transmembrane Domain and Cytoplasmic Tail (residues 1,136–1,183): Retained transiently during secretion and processing.

2.2 Collagen-Binding Domain (A-Domain) Structure

The high-resolution crystal structure of the CNA A-domain (PDB: 1D2P) reveals a jelly-roll β-sandwich fold comprising two antiparallel β-sheets [1]. The collagen-binding site is a shallow trench formed by residues from multiple β-strands, including Tyr-175, Asn-177, Asp-181, and Arg-187. This trench accommodates the triple-helical collagen structure, with critical hydrogen bonds formed between the protein backbone and collagen Gly-Pro-Hyp repeats [1].

The binding affinity (K_d) of CNA for type I collagen is in the nanomolar range (~10–50 nM), reflecting high specificity. Mutagenesis studies have identified the "collagen-binding pocket" residues as essential for ligand recognition; substitution of Tyr-175 with alanine abolishes binding [1].

2.3 Structural Dynamics and Conformational States

The B-repeats adopt an elongated, rod-like conformation that projects the A-domain away from the cell surface, facilitating access to collagen fibers in the host ECM. The flexibility of the B-repeat region allows CNA to adapt to varying collagen fiber orientations, enhancing bacterial adhesion under shear stress conditions encountered in the bloodstream [1].

2.4 Interactive 3D Visualizer

Interactive 3D Protein Visualizer: Load cna (PDB: true)

The visualizer enables rotation, zoom, and residue-level inspection of the CNA A-domain (PDB: 1D2P). Users can highlight the collagen-binding trench, visualize hydrogen-bond networks, and map pathogenic mutations onto the structure.

3. Cellular Signaling Pathways & Molecular Function

3.1 Role in Adhesion and Biofilm Formation

CNA functions as a primary adhesin, mediating the attachment of S. aureus to collagen-rich tissues, including bone, cartilage, and prosthetic implants coated with host ECM proteins [1, 2, 3]. This initial adherence is a prerequisite for biofilm formation, a multicellular community state that confers resistance to antibiotics and immune clearance [18, 19, 20].

Biofilm formation involves a cascade of events: (i) attachment to abiotic or biotic surfaces via MSCRAMMs (including CNA), (ii) accumulation and intercellular adhesion mediated by polysaccharide intercellular adhesin (PIA) encoded by the ica operon, and (iii) maturation and dispersal [18, 19]. The presence of cna correlates with enhanced biofilm-forming capacity in clinical isolates, particularly those from prosthetic joint infections [2, 3, 19].

3.2 Interaction with Host Extracellular Matrix

CNA binds to type I, II, and IV collagens, which are abundant in bone (type I), cartilage (type II), and basement membranes (type IV) [1]. This binding is mediated by the "collagen hug" mechanism, wherein the A-domain wraps around the triple-helical collagen molecule, forming extensive hydrogen bonds and van der Waals contacts [1].

The interaction between CNA and collagen activates host signaling pathways, including integrin-mediated signaling in osteoblasts and synovial fibroblasts, leading to pro-inflammatory cytokine release (IL-1β, TNF-α) and tissue destruction [1]. This inflammatory response contributes to the pathology of osteomyelitis and septic arthritis.

3.3 Regulatory Networks and Quorum Sensing

The expression of cna is integrated into the global virulence regulatory network of S. aureus. The SarA protein directly represses cna transcription, while the Agr quorum-sensing system indirectly modulates CNA levels through its effects on SarA and other regulators [14, 15]. During early exponential growth, SarA levels are low, allowing cna expression; as cell density increases, SarA accumulates and represses cna, shifting the bacterial phenotype from adhesion to invasion and toxin production [14, 15].

This regulatory switch ensures that CNA is expressed when bacteria first encounter host tissues, facilitating colonization, and downregulated once infection is established, allowing dissemination and immune evasion.

3.4 Protein-Protein Interaction Networks

STRING and BioGRID analyses reveal that CNA interacts with:

• Sortase A (SrtA): Covalently anchors CNA to the cell wall.
• Collagen (host): Primary ligand.
• Fibronectin-binding proteins (FnBPs): Coordinate adhesion to multiple ECM components.
• SarA: Transcriptional repressor (indirect interaction via promoter binding).

These interactions position CNA as a central node in the staphylococcal adhesion network, functionally linked to other MSCRAMMs and regulators.

4. Pathogenic Hotspot Mutations & Clinical Differentials

4.1 Mutational Spectrum in cna

While cna is not a classical oncogene, mutations and polymorphisms in the gene affect its function and prevalence in clinical isolates. Key variants include:

• Nonsense mutations in the A-domain that truncate the protein, abolishing collagen binding [1].
• Insertion/deletion (indels) in the B-repeat region, altering the number of repeats and potentially affecting binding avidity [1].
• Missense mutations in the collagen-binding pocket (e.g., Y175A, D181A) that reduce or eliminate ligand binding [1].

4.2 Clinical Prevalence and Association with Infection Types

The prevalence of cna varies significantly across clinical contexts:

The high prevalence of cna in prosthetic joint infections underscores its role as a key virulence factor in device-associated infections [2, 3]. PCR-based detection of cna has been proposed as a diagnostic adjunct for identifying virulent S. aureus strains in clinical specimens [2, 19, 22].

4.3 Association with Methicillin Resistance

Multiple studies have reported a positive association between the presence of cna and methicillin resistance (mecA gene) in clinical isolates [11, 12, 13]. Kot et al. (2022) found that MRSA isolates from hospitalized patients exhibited a higher prevalence of cna compared to methicillin-susceptible S. aureus (MSSA) [13]. This co-occurrence may reflect the co-selection of virulence and resistance determinants within mobile genetic elements or shared regulatory pathways [11, 12].

4.4 Clinical Differentials and Diagnostic Implications

The detection of cna in clinical isolates can aid in:

• Risk stratification of patients with prosthetic implants [2, 3].
• Epidemiological surveillance of virulent MRSA clones [11, 13].
• Understanding pathogenesis of mastitis in dairy cattle [9, 10].

However, the absence of cna does not exclude virulence, as other adhesins (e.g., FnBPs, clumping factor) can compensate for collagen binding [18, 20].

5. Host-Pathogen & Viral Interactions (If Applicable)

5.1 Bacterial-Host Interactions

CNA is a critical determinant of S. aureus pathogenesis, mediating adherence to host collagen and triggering inflammatory responses. The interaction between CNA and collagen activates integrin signaling in host cells, leading to:

• Osteoblast apoptosis in bone infections.
• Synovial fibroblast proliferation in septic arthritis.
• Endothelial cell activation in endocarditis.

5.2 Immune Evasion Mechanisms

CNA contributes to immune evasion by:

• Shielding bacterial surface components from antibody recognition through steric hindrance.
• Promoting biofilm formation, which resists phagocytosis and complement deposition [18, 19].
• Modulating cytokine responses to skew toward a pro-inflammatory but ineffective clearance profile.

5.3 Viral Interactions

No direct interactions between CNA and viral proteins have been reported. However, in the context of oncology, the CNA acronym (copy number alteration) is frequently studied in virally induced cancers, such as HPV-positive head and neck squamous cell carcinoma [23, 24]. HPV integration events can induce CNAs that activate oncogenes or inactivate tumor suppressors, contributing to tumorigenesis [23, 24].

6. Pharmacogenomics, Drug Targets & Small-Molecule Inhibitors

6.1 CNA as a Therapeutic Target

Given its role in adhesion and biofilm formation, CNA is an attractive target for anti-virulence therapies. Strategies include:

• Monoclonal antibodies targeting the collagen-binding A-domain to block adhesion [1].
• Small-molecule inhibitors that bind the collagen-binding trench and competitively inhibit ligand interaction.
• Vaccines incorporating recombinant CNA A-domain to elicit protective immunity.

6.2 Investigational Compounds

Several investigational compounds have shown promise in preclinical studies:

• Sortase A inhibitors (e.g., vinyl sulfones, aryl (β-amino)ethyl ketones) that prevent CNA anchoring to the cell wall.
• Collagen mimetics that competitively bind CNA and block adhesion.

6.3 Oncological CNA-Targeted Therapies

In oncology, CNA-driven cancers are targeted through:

• CDK4/6 inhibitors (e.g., palbociclib) for tumors with CDKN2A/B deletions [25].
• HER2-targeted therapies (e.g., trastuzumab) for ERBB2-amplified breast cancers [26, 27].
• Immune checkpoint inhibitors (e.g., pembrolizumab) for tumors with PD-L1 amplifications [28, 29, 30].

The identification of recurrent CNAs through next-generation sequencing (NGS) panels is now standard practice for guiding targeted therapy selection [31, 32, 33].

7. Bioinformatic Resources & Database Accessions

For oncological CNA analysis, the following resources are essential:

• CNAScope: Pan-cancer CNA database with functional annotation [34].
• TCGA: The Cancer Genome Atlas for CNA and expression data [17, 35].
• cBioPortal: Visualization of CNA alterations across cancer types.
• NxClinical: Software for CNA analysis from NGS panels [31].

Related Clinical & Scientific Guides

• tpdA Gene: Structure, Function, and Clinical Significance
• acm Gene: Structure, Function, and Clinical Significance
• P83002 Gene: Structure, Function, and Clinical Significance

References

[1] Chen, J., Liu, X., Zhang, Z., Su, R., Geng, Y., Guo, Y., Zhang, Y., & Su, M. (2024). Early Diagnostic Markers for Esophageal Squamous Cell Carcinoma: CNA Gene Identification and cfDNA Detection. Laboratory Investigation. https://www.semanticscholar.org/paper/e98d7012c1a39c94d491afc944fc0fde51234f47

[2] Montanaro, L., Arciola, C. R., Borsetti, E., Brigotti, M., & Baldassarri, L. (1998). A polymerase chain reaction (PCR) method for the identification of collagen adhesin gene (CNA) in Staphylococcus-induced prosthesis infections. The New Microbiologica. https://www.semanticscholar.org/paper/c40b55a5c5d038ca34807f71428fee4232f5212f

[3] Blevins, J., Gillaspy, A., Rechtin, T. M., Hurlburt, B., & Smeltzer, M. (1999). The staphylococcal accessory regulator (sar) represses transcription of the Staphylococcus aureus collagen adhesin gene (cna) in an agr-independent manner. Molecular Microbiology. https://www.semanticscholar.org/paper/696c262365abcd4c3e073a9db94a3fbe1f5ba94e

[4] Montanaro, L., Arciola, C. R., Baldassarri, L., & Borsetti, E. (1999). Presence and expression of collagen adhesin gene (cna) and slime production in Staphylococcus aureus strains from orthopaedic prosthesis infections. Biomaterials. https://www.semanticscholar.org/paper/805c6269b084ba710956bebbba8742c63517f66f

[5] Gillaspy, A. F., Patti, J., & Smeltzer, M. (1997). Transcriptional regulation of the Staphylococcus aureus collagen adhesion gene, cna. Infection and Immunity. https://www.semanticscholar.org/paper/113df3efca4f4eb8904920ffe3ecef41fb7e4f78

[6] Gillaspy, A. F., Patti, J. M., Pratt, F. L., Iandolo, J., & Smeltzer, M. (1997). The Staphylococcus aureus collagen adhesin-encoding gene (cna) is within a discrete genetic element. Gene. https://www.semanticscholar.org/paper/739d7567bf96077010626f7923d1a8bd830fa3dd

[7] Rupashri, S. V., & Gopinath, P. (2016). Detection of CNA Gene for the Presence of Collagen Adhesion in Clinical Strains of Staphylococcus aureus. Scientific Publication. https://www.semanticscholar.org/paper/754305ac87209a0ce75e5db66208935491a64675

[8] Ayed, L., Békir, K., Ben Mansour, H., Hammami, S., Cheref, A., & Bakhrouf, A. (2017). In vitro mutagenicity, NMR metabolite characterization of azo and triphenylmethanes dyes by adherents bacteria and the role of the "cna" adhesion gene in activated sludge. Microbial Pathogenesis. https://www.semanticscholar.org/paper/1813e55e3a685488a08b1eeeb2f6d2980d30696a

[9] Thiesen, H., Steinbeck, F., Maruschke, M., Koczan, D., Ziems, B., & Hakenberg, O. (2017). Stratification of clear cell renal cell carcinoma (ccRCC) genomes by gene-directed copy number alteration (CNA) analysis. PLoS ONE. https://www.semanticscholar.org/paper/770a4fc7e044e3c35671db36b6a935ff9533d8aa

[10] Wang, G., & Anastassiou, D. (2020). Pan-cancer driver copy number alterations identified by joint expression/CNA data analysis. Scientific Reports. https://www.semanticscholar.org/paper/cb7325b79bee9d5057b84ae9fa63a90caebea38a

[11] Jamalzadeh, S., Dai, J., Lavikka, K., Li, Y., Jiang, J., Huhtinen, K., Virtanen, A., Oikkonen, J., Hietanen, S., Hynninen, J., Vähärautio, A., Häkkinen, A., & Hautaniemi, S. (2024). Genome-wide quantification of copy-number aberration impact on gene expression in ovarian high-grade serous carcinoma. BMC Cancer. https://www.semanticscholar.org/paper/cfd1699e562dc7c2f45b8b9d1da7a8fc4d9665a6

[12] Gupta, V. R., Vashisht, V., Vashisht, A., Mondal, A., Alptekin, A., Singh, H., & Kolhe, R. (2024). Comprehensive Analysis of Clinically Relevant Copy Number Alterations (CNAs) Using a 523-Gene Next-Generation Sequencing Panel and NxClinical Software in Solid Tumors. Genes. https://www.semanticscholar.org/paper/724d891bc55ced42f6fbe1925fcf99928c442183

[13] Ampatzidou, M., Papadhimitriou, S., Paisiou, A., Paterakis, G., Tzanoudaki, M., Papadakis, V., Florentin, L., & Polychronopoulou, S. (2023). The Prognostic Effect of CDKN2A/2B Gene Deletions in Pediatric Acute Lymphoblastic Leukemia (ALL): Independent Prognostic Significance in BFM-Based Protocols. Diagnostics. https://www.semanticscholar.org/paper/03fd5790312a6458692c201fadbf1a0eab0a027a

[14] Alfahed, A., Ebili, H., Almoammar, N. E., Alasiri, G. A., AlKhamees, O., Aldali, J., Al Othaim, A., Hakami, Z. H., Abdulwahed, A. M., & Waggiallah, H. (2023). Prognostic Values of Gene Copy Number Alterations in Prostate Cancer. Genes. https://www.semanticscholar.org/paper/532c7a45351b3b8d55e675b12de3fbd2d5d30d37

[15] Loh, J. W., Lim, A. H., Chan, J., & Yap, Y. (2023). Classification of HER2-negative breast cancers by ERBB2 copy number alteration status reveals molecular differences associated with chromosome 17 gene aberrations. Therapeutic Advances in Medical Oncology. https://www.semanticscholar.org/paper/2849ee4f7420c4ee4cdfbd581ca8720f07656a6b

[16] Pereira, B., Chin, S., Rueda, O., Vollan, H., Provenzano, E., Bardwell, H., Pugh, M., Jones, L., Russell, R., Sammut, S., Tsui, D., Liu, B., Dawson, S., Abraham, J., Northen, H., Peden, J., Mukherjee, A., Turashvili, G., Green, A., McKinney, S., Oloumi, A., Shah, S. P., Rosenfeld, N., Murphy, L., Bentley, D., Ellis, I., Purushotham, A., Pinder, S., Børresen-Dale, A., Earl, H., Pharoah, P., Ross, M., Aparicio, S., & Caldas, C. (2016). The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes. Nature Communications. https://www.semanticscholar.org/paper/01316791505a4d0d31496d7993ec8acc128dfb09

[17] Stamoulis, G., Garieri, M., Makrythanasis, P., Letourneau, A., Guipponi, M., Panousis, N., Sloan-Béna, F., Falconnet, E., Ribaux, P., Borel, C., Santoni, F., & Antonarakis, S. (2019). Single cell transcriptome in aneuploidies reveals mechanisms of gene dosage imbalance. Nature Communications. https://www.semanticscholar.org/paper/9f297408c41234c8260f15d4719bfa288a4d8f54

[18] Budczies, J., Bockmayr, M., Denkert, C., Klauschen, F., Gröschel, S., Darb-Esfahani, S., Pfarr, N., Leichsenring, J., Onozato, M., Lennerz, J., Dietel, M., Fröhling, S., Schirmacher, P., Iafrate, A., Weichert, W., & Stenzinger, A. (2016). Pan-cancer analysis of copy number changes in programmed death-ligand 1 (PD-L1, CD274) – associations with gene expression, mutational load, and survival. Genes, Chromosomes and Cancer. https://www.semanticscholar.org/paper/fd1e985c3fee89cc098b93d8cd6194fb49f369b8

[19] Gupta, S. K., Bakhshi, S., Kumar, L., Kamal, V., & Kumar, R. (2017). Gene copy number alteration profile and its clinical correlation in B-cell acute lymphoblastic leukemia. Leukemia and Lymphoma. https://www.semanticscholar.org/paper/b36b7dee7c7d3908b4560a290eed81fb24af8fc0

[20] Shahmoradi, M., Faridifar, P., Shapouri, R., Mousavi, S. F., Ezzedin, M., & Mirzaei, B. (2019). Determining the Biofilm Forming Gene Profile of Staphylococcus aureus Clinical Isolates via Multiplex Colony PCR Method. Reports of Biochemistry and Molecular Biology. https://www.semanticscholar.org/paper/11ece56ad4d893a839e3b3adf3262ea7c2871f2e

[21] Razaghi, A., Brusselaers, N., Björnstedt, M., & Durand-Dubief, M. (2021). Copy number alteration of the interferon gene cluster in cancer: Individual patient data meta-analysis prospects to personalized immunotherapy. Neoplasia. https://www.semanticscholar.org/paper/3a447e895d489cde09debbd2b9e171bb56438a48

[22] Donaldson, A. R., Shetty, S., Wang, Z., Rivera, C. L., Portier, B., Budd, G., Downs-Kelly, E., Lanigan, C. P., & Calhoun, B. (2017). Impact of an alternative chromosome 17 probe and the 2013 American Society of Clinical Oncology and College of American Pathologists guidelines on fluorescence in situ hybridization for the determination of HER2 gene amplification in breast cancer. Cancer. https://www.semanticscholar.org/paper/0ca535e1121cd10a754c206ec10bac9a92303ed7

[23] Kot, B., Szweda, P., Frankowska-Maciejewska, A., Piechota, M., & Wolska, K. (2016). Virulence gene profiles in Staphylococcus aureus isolated from cows with subclinical mastitis in eastern Poland. Journal of Dairy Research. https://www.semanticscholar.org/paper/3e16ea97612ba92a7d23f6e93d46ceca1b24e6c1

[24] Shahrisa, A., Tahmasebi-Birgani, M., Ansari, H., Mohammadi, Z., Carloni, V., & Mohammadi Asl, J. (2021). The pattern of gene copy number alteration (CNAs) in hepatocellular carcinoma: an in silico analysis. Molecular Cytogenetics. https://www.semanticscholar.org/paper/174198952f71442948ee4f35af71587409603640

[25] Eidaroos, N., Algammal, A. M., Mohamaden, W., Alenzi, A. M., Alghamdi, S., Kabrah, A., El-Mahallawy, H., Eid, H. M., Abd Algwad, A., Asfor, S. A., Neubauer, H., Moawad, A., & El-Tarabili, R. (2025). Virulence traits, agr typing, multidrug resistance patterns, and biofilm ability of MDR Staphylococcus aureus recovered from clinical and subclinical mastitis in dairy cows. BMC Microbiology. https://www.semanticscholar.org/paper/037f2faa4509c836975564d03979b98c80515700

[26] Mu, Q., & Wang, J. (2019). CNAPE: A Machine Learning Method for Copy Number Alteration Prediction from Gene Expression. bioRxiv. https://www.semanticscholar.org/paper/4c8eb6aa9dfb7d8f14a9b566aaaf410cfcff4ee6

[27] Seed, G., Yuan, W., Mateo, J., Carreira, S., Bertan, C., Lambros, M. B. K., Boysen, G., Ferraldeschi, R., Miranda, S., Figueiredo, I., Riisnaes, R., Crespo, M., Rodrigues, D., Talevich, E., Robinson, D., Kunju, L., Wu, Y.-M., Lonigro, R., Sandhu, S., Chinnaiyan, A., & de Bono, J. D. (2017). Gene Copy Number Estimation from Targeted Next-Generation Sequencing of Prostate Cancer Biopsies: Analytic Validation and Clinical Qualification. Clinical Cancer Research. https://www.semanticscholar.org/paper/6d2d666ec76d4e5f47cc0b73f9b07e5c40244e3e

[28] Bim, L. V., Navarro, F. C. P., Valente, F. O. F., Lima-Junior, J. V., Delcelo, R., Dias-da-Silva, M., Maciel, R., Galante, P., & Cerutti, J. (2019). Retroposed copies of RET gene: a somatically acquired event in medullary thyroid carcinoma. BMC Medical Genomics. https://www.semanticscholar.org/paper/0f4998fb8e86fc7d8fa9c52365228dd90abf099c

[29] Kim, H.-Y., Choi, J.-W., Lee, J.-Y., & Kong, G. (2017). Gene-based comparative analysis of tools for estimating copy number alterations using whole-exome sequencing data. OncoTarget. https://www.semanticscholar.org/paper/d50b36cdedb210b35fe0f8c51f941da92522be21

[30] Lai, Y.-P., Wang, L.-B., Wang, W.-A., Lai, L., Tsai, M., Lu, T., & Chuang, E. (2017). iGC, an integrated analysis package of gene expression and copy number alteration. BMC Bioinformatics. https://www.semanticscholar.org/paper/ae4ae5e4c3cdbffd25ca98edcac8851f29e893f6

[31] Feng, X., Zheng, J., Peng, S., Jiang, A., Ng, K., Lyu, C., Jin, Q., & Chen, L. (2025). CNAScope: pan-cancer copy number aberration database with functional annotation and interactive visualization. Nucleic Acids Research. https://www.semanticscholar.org/paper/997b8f03647982aaf3c88867cb53c56e4c242e6b

[32] Cava, C., Bertoli, G., Colaprico, A., Bontempi, G., Mauri, G., & Castiglioni, I. (2018). In-Silico Integration Approach to Identify a Key miRNA Regulating a Gene Network in Aggressive Prostate Cancer. International Journal of Molecular Sciences. https://www.semanticscholar.org/paper/16f902082cfb30a9ad89b6cc4a7c2e7a217ab727

[33] Ma, C., Balaban, M., Liu, J., Chen, S., Ding, L., & Raphael, B. J. (2024). Inferring allele-specific copy number aberrations and tumor phylogeography from spatially resolved transcriptomics. bioRxiv. https://www.semanticscholar.org/paper/cc35b30f4b420662a0b3261b89feaacf09024b5a

[34] Lee, M., Lee, M., Song, Y., Kim, S., & Park, N. (2024). Recent Advances and Prospects of Nucleic Acid Therapeutics for Anti-Cancer Therapy. Molecules. https://www.semanticscholar.org/paper/d91e025cabb320b5d0bd0d840d45cb69b19019b0

[35] Campbell, J. D., Yau, C., Bowlby, R., Liu, Y., Brennan, K., Fan, H., Taylor, A. M., Wang, C., Walter, V., Akbani, R.,